Post-operative systemic chemo and RT did not improve OS in high-risk patients with stage I endometrial cancer, according to Rachelle Findley, MD, et al.
Findings from a study presented at the 2021 SGO Virtual Annual Meeting on Women's Cancer, frail patients with ovarian cancer who undergo surgery at institutions with higher surgical volume have lower…
In a session presented at the 2021 SGO Annual Meeting on Women’s Cancer Rebecca Kristeleit, PhD, UCL Cancer Institute, London, shared findings from the ARIEL4 study on rucaparib versus chemotherapy.
A Swedish study found that women who received the quadrivalent HPV vaccine were less likely to contract invasive cervical cancer than those who had not.
According to the ARIEL3 study, _______ extended PFS for ovarian cancer despite toxicities?
Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Focusing on patient-centered outcomes from the ARIEL3 trial, rucaparib extended PFS in the maintenance setting for ovarian cancer despite toxicities.
True or False: Pembrolizumab provided a durable clinical response in cisplatin-ineligible patients with advanced urothelial carcinoma and is associated with prolonged OS.
Tumor-specific TP53 variants were detected in Papanicolaou tests for routine cervical cancer screenings up to 6 years before ovarian cancer diagnosis.